You are using an older browser version. Please use a supported version for the best MSN experience.

HSA recalls 3 brands of high blood pressure medicine

Connected to India logo Connected to India 29/3/2019 CtoI News Desk

The Health Sciences Authority (HSA) is recalling three brands of blood pressure medicines which contain a losartan ingredient manufactured by Hetero Labs.

These products were found to contain trace amounts of a nitrosamine impurity, which are above internationally acceptable levels. 

HSA urged patients not to stop treatment on their own as there is no immediate health risk associated with taking the affected medicines. Healthcare professionals have been advised review the medicine and treatment plans of their patients.

Meanwhile, the authorities are working with companies and international regulatory agencies to verify the cause of contamination, and to formulate measures to address the issue. 

a screenshot of a cell phone: Image screenshot: HSA © Connected to India Image screenshot: HSA

"There is no immediate health risk associated with taking the affected medicines, and patients are advised not to stop or change treatment on their own," said Professor Ding Zee Pin, Cardiologist in the National Heart Centre Singapore and HSA’s Expert Panel on Nitrosamines. 

Stopping the medicine without replacement of other equivalent medication can increase the risk of poor control of blood pressure, he added. 

Consumers should consult their healthcare provider if you are unsure if you are taking an affected brand, HSA said. 

Affected products: 

a close up of a card: Hyperten 100mg. Photo courtesy: HSA

Hyperten 100mg. Photo courtesy: HSA

More from Connected to india

Connected to India
Connected to India
image beaconimage beaconimage beacon